Invited commentary: Defining incident chronic kidney disease in epidemiologic study settings

American Journal of Epidemiology

Volumn 170, Issue 4, 2009, Pages 425-427

  Tonna, Stephen J ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Albuminuria; Chronic disease; Creatinine; Diagnostic techniques and procedures; Glomerular filtration rate; Kidney diseases; Renal insufficiency, chronic

Indexed keywords

CREATININE;

ALBUMINURIA; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; NOTE; PREVALENCE; RISK FACTOR;

BIOLOGICAL MARKERS; CREATININE; DATA COLLECTION; EPIDEMIOLOGIC METHODS; GLOMERULAR FILTRATION RATE; HOSPITALIZATION; HUMANS; INCIDENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TERMINOLOGY AS TOPIC; UNITED STATES;

EID: 68149173153     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp148     Document Type: Note

References (10)

1. US Renal Data System. USRDS 2008 Annual Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 2008.
2. Coresh J, Selvin E, Stevens LA, et ai, Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17): 2038-2047.
3. World Health Organization. Preventing Chronic Diseases: A Vital Investment. WHO Global Report. Geneva, Switzerland: World Health Organization; 2005.
4. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003;42(5):1050-1065.
5. Hsu CC, Kao WH, Coresh J, et al. Apolipoprotein E and progression of chronic kidney disease. JAMA. 2005;293(23): 2892-2899.
6. Hsu CC, Bray MS, Kao WH, et al. Genetic variation of the renin-angiotensin system and chronic kidney disease progression in black individuals in the Atherosclerosis Risk in Communities Study. J Am Soc Nephrol. 2006; 17(2): 504-512.
7. Merkin SS, Coresh J, Roux AV, et al. Area socioeconomic status and progressive CKD: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2005;46(2): 203-213.
8. Muntner P, Coresh J, Smith JC, et al. Plasma lipids and risk of developing renal dysfunction: the Atherosclerosis Risk in Communities Study. Kidney Int. 2000;58(1): 293-301.
9. Krop JS, Coresh J, Chambless LE, et al. A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities Study. Arch Intern Med. 1999;159(15):1777-1783.
10. Bash LD, Coresh J, Köttgen A, et al. Defining incident chronic kidney disease in the research setting: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2009; 170(4): 414-424.